Neela Kumar

Neela Kumar has extensive experience in health economics, policy, and evidence strategy, currently serving as Director of Value and Evidence Strategy at Alnylam Pharmaceuticals. Previously, Neela held the position of Director for Payer & Real World Evidence at AstraZeneca and worked as Associate Director of Real World Value and Evidence at The Janssen Pharmaceutical Companies of Johnson & Johnson. Earlier roles include Manager of Health Economics and Outcomes Research Partnerships at Novo Nordisk and Healthcare Policy Advisor at Princeton Wound Care Center. Neela's academic background includes a Doctor of Philosophy (PhD) in Health Policy and Management and a Master of Science in Public Health with a focus on Health Policy and Management, both obtained from the University of North Carolina at Chapel Hill.